1. Home
  2. ROIV vs IHG Comparison

ROIV vs IHG Comparison

Compare ROIV & IHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$38.99

Market Cap

28.7B

Sector

Health Care

ML Signal

HOLD

Logo Intercontinental Hotels Group

IHG

Intercontinental Hotels Group

HOLD

Current Price

$154.60

Market Cap

25.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
IHG
Founded
2014
1777
Country
United Kingdom
United Kingdom
Employees
721
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
28.7B
25.1B
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
ROIV
IHG
Price
$38.99
$154.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
2
Target Price
$28.94
N/A
AVG Volume (30 Days)
8.5M
145.3K
Earning Date
05-28-2026
08-02-2016
Dividend Yield
N/A
1.25%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,260,000.00
N/A
Revenue This Year
N/A
$9.46
Revenue Next Year
$744.61
$5.51
P/E Ratio
N/A
$29.84
Revenue Growth
N/A
N/A
52 Week Low
$14.50
$117.29
52 Week High
$42.50
$175.89

Technical Indicators

Market Signals
Indicator
ROIV
IHG
Relative Strength Index (RSI) 55.79 43.81
Support Level $33.15 $153.22
Resistance Level $42.50 $164.69
Average True Range (ATR) 1.45 2.13
MACD 0.05 -0.33
Stochastic Oscillator 60.80 26.17

Price Performance

Historical Comparison
ROIV
IHG

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About IHG Intercontinental Hotels Group

InterContinental Hotels Group operates 1 million rooms across 20 brands addressing the midscale through luxury segments, as of Dec. 31, 2025. Holiday Inn and Holiday Inn Express constitute the largest brand, while Hotel Indigo, Even, Hualuxe, Kimpton, and Voco are newer lifestyle brands experiencing strong demand. The company launched a midscale brand, Avid, in 2017 and closed on a 51% stake in Regent Hotels in 2018. It acquired Six Senses in 2019 and launched another midscale brand, Garner, in 2023, followed by a premium conversion brand, Noted Collections, in 2026. Managed and franchised represent 99% of total rooms. As of Dec. 31, 2025, the Americas represented 52% of total rooms, with Greater China accounting for 20% and Europe, Asia, the Middle East, and Africa making up 28%.

Share on Social Networks: